Lead Product(s) : Vitamin B1
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Alzheimer's Pill Begins Trials at 50 Centers Across the U.S.
Details : Benfotiamine is a synthetic version of vitamin B1 (thiamine), which is being evaluated as a treatment for mild cognitive impairment and early Alzheimer's disease.
Product Name : Benfotiamine
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 23, 2024
Lead Product(s) : Vitamin B1
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
